Kikuchi-Fujimoto disease: a case report
DOI:
https://doi.org/10.18203/2349-2902.isj20261587Keywords:
Kikuchi-Fujimoto disease, Histiocytic necrotizing lymphadenitis, Cervical lymphadenitis, LymphadenopathyAbstract
Kikuchi-Fujimoto disease is unique because it mimics serious illnesses yet has a benign course, requiring awareness to avoid misdiagnosis. Its novelty lies in its mysterious origin, possible autoimmune associations, and evolving clinical profile in the era of new infections and immunologic events. Given the potential for recurrence and its association with autoimmune diseases like systemic lupus erythematosus, further research is needed to clarify its pathogenesis and guide standardized treatment protocols. A 19-year-old Marathi (Indo-Aryan) female presented with multiple, painless, gradually enlarging neck swellings and occasional low-grade fever without systemic symptoms. Similar complaints occurred in childhood. On examination, firm, mobile, non-tender lymph nodes were found in the posterior neck triangle, with no skin changes or lymphadenopathy elsewhere. FNAC suggested reactive lymphadenitis, and antibiotics were ineffective. An excision biopsy was performed, and histopathology confirmed the diagnosis of Kikuchi-Fujimoto disease. The patient was treated with symptomatic treatment with good results. The aim of the case report is to increase awareness of this disease so that it can be recognized early and prevent misdiagnosis and subsequent over treatment. The best way to diagnose this non-specific lymphadenopathy is to do a biopsy of the lymph node. Once diagnosed, it can be managed conservatively as it is mostly self-limiting.
References
Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M. Kikuchi–Fujimoto disease: analysis of 244 cases. Clin Rheumatol. 2007;26:50-4.
Norris AH, Krasinskas AM, Salhany KE, Gluckman SJ. Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. Am J Med. 1996;101(4):401-5.
Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004;122(1):141-52.
Hutchinson CB, Wang E. Kikuchi-fujimoto disease. Arc Pathol Laboratory Med. 2010;134(2):289-93.
Jamal AB. Kikuchi fujimoto disease. Cli Med Arthritis Musculoskele Disorder. 2012;5:CMAMD-S9895.
Deaver D, Horna P, Cualing H, Sokol L. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease. Cancer Control. 2014;21(4):313-21.
Akhavanrezayat A, Cooper JD, Hassan M, Pham BH, Nguyen QD, Farr AK. Bilateral preretinal hemorrhage associated with Kikuchi-Fujimoto disease. Am J Ophthalmol Case Rep. 2021;22:101041.
Mahajan T, Merriman RC, Stone MJ. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): report of a case with other autoimmune manifestations. Proc. 2007;20(2):149-51.
Xu S, Sun W, Liu J. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures. BMC Oral Health. 2019;19:223.
Dumas G, Prendki V, Haroche J, Amoura Z, Cacoub P, Galicier L, et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine. 2014;93(24):372-82.
Erhamamci S, Reyhan M, Kocer NE. Kikuchi-Fujimoto disease as a rare cause of benign lymphadenopathy and (18)F-FDG PET/CT findings. Hellenic J Nuclear Med. 2014;17(1):41-4.
Bogusz AM, Bhargava P. Recurrent histiocytic necrotizing lymphadenitis with a long latency in a patient with autoimmunity: a case report and review of literature. Int J Surg Pathol. 2013;21(3):287-96.
Kuo T. A Clinicopathologic Study of 79 Cases with an Analysis of Histologic Subtypes, Immunohistology, and DNA Ploidy. Am J Surg Pathol. 1995;19(7):798-809.
Rezayat T, Carroll MB, Ramsey BC, Smith A. A case of relapsing kikuchi-fujimoto disease. Case Rep Otolaryngol. 2013;2013:364795.
Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, et al. Recurrent Kikuchi-Fujimoto disease successfully treated by the concomitant use of hydroxychloroquine and corticosteroids. Intern Med. 2017;56(24):3373-7.
Rezai K, Kuchipudi S, Chundi V, Ariga R, Loew J, Sha BE. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004;39(12):e124-6.